- Home
- LDWY vs CNSP Comparison
LDWY vs CNSP Comparison
Compare LDWY & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDWY
- CNSP
- Stock Information
- Founded
- LDWY 1990
- CNSP 2017
- Country
- LDWY United States
- CNSP United States
- Employees
- LDWY N/A
- CNSP N/A
- Industry
- LDWY Advertising
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- LDWY Consumer Discretionary
- CNSP Health Care
- Exchange
- LDWY Nasdaq
- CNSP Nasdaq
- Market Cap
- LDWY 8.2M
- CNSP 6.5M
- IPO Year
- LDWY 1991
- CNSP 2019
- Fundamental
- Price
- LDWY $4.34
- CNSP $0.09
- Analyst Decision
- LDWY
- CNSP Strong Buy
- Analyst Count
- LDWY 0
- CNSP 1
- Target Price
- LDWY N/A
- CNSP $0.50
- AVG Volume (30 Days)
- LDWY 5.6K
- CNSP 17.2M
- Earning Date
- LDWY 03-31-2025
- CNSP 03-31-2025
- Dividend Yield
- LDWY N/A
- CNSP N/A
- EPS Growth
- LDWY N/A
- CNSP N/A
- EPS
- LDWY N/A
- CNSP N/A
- Revenue
- LDWY $31,581,000.00
- CNSP N/A
- Revenue This Year
- LDWY N/A
- CNSP N/A
- Revenue Next Year
- LDWY N/A
- CNSP N/A
- P/E Ratio
- LDWY N/A
- CNSP N/A
- Revenue Growth
- LDWY N/A
- CNSP N/A
- 52 Week Low
- LDWY $3.02
- CNSP $0.08
- 52 Week High
- LDWY $6.88
- CNSP $23.90
- Technical
- Relative Strength Index (RSI)
- LDWY 47.81
- CNSP 37.39
- Support Level
- LDWY $4.13
- CNSP $0.09
- Resistance Level
- LDWY $4.55
- CNSP $0.10
- Average True Range (ATR)
- LDWY 0.22
- CNSP 0.01
- MACD
- LDWY -0.02
- CNSP -0.00
- Stochastic Oscillator
- LDWY 39.98
- CNSP 26.90
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two Industry Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.